Tuesday, February 3, 2009

Prasugrel Review Proceeds Without Key Safety Experts

Several outside experts were surprised FDA didn't invite its Safety and Risk Management Committee to assess Lilly's prasugrel.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)